These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20814720)

  • 21. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.
    Hartshorn CM; Bradbury MS; Lanza GM; Nel AE; Rao J; Wang AZ; Wiesner UB; Yang L; Grodzinski P
    ACS Nano; 2018 Jan; 12(1):24-43. PubMed ID: 29257865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precision arrows: Navigating breast cancer with nanotechnology siRNA.
    Jayaswal N; Srivastava S; Kumar S; Belagodu Sridhar S; Khalid A; Najmi A; Zoghebi K; Alhazmi HA; Mohan S; Tambuwala MM
    Int J Pharm; 2024 Sep; 662():124403. PubMed ID: 38944167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical developments in nanotechnology for cancer therapy.
    Heidel JD; Davis ME
    Pharm Res; 2011 Feb; 28(2):187-99. PubMed ID: 20549313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NCI Alliance for Nanotechnology in Cancer - from academic research to clinical interventions.
    Grodzinski P; Liu CH; Hartshorn CM; Morris SA; Russell LM
    Biomed Microdevices; 2019 Mar; 21(2):32. PubMed ID: 30904965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in development of nanoparticle-based therapeutics.
    Desai N
    AAPS J; 2012 Jun; 14(2):282-95. PubMed ID: 22407288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of albumin based approaches in nanomedicine: Imaging, targeting and drug delivery.
    Bhushan B; Khanadeev V; Khlebtsov B; Khlebtsov N; Gopinath P
    Adv Colloid Interface Sci; 2017 Aug; 246():13-39. PubMed ID: 28716187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanomedicine for the management of lung and blood diseases.
    Buxton DB
    Nanomedicine (Lond); 2009 Apr; 4(3):331-9. PubMed ID: 19331540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy.
    Zheng M; Tao W; Zou Y; Farokhzad OC; Shi B
    Trends Biotechnol; 2018 May; 36(5):562-575. PubMed ID: 29422412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
    Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug delivery and nanoparticles:applications and hazards.
    De Jong WH; Borm PJ
    Int J Nanomedicine; 2008; 3(2):133-49. PubMed ID: 18686775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes and nanotechnology in drug development: focus on neurological targets.
    Ramos-Cabrer P; Campos F
    Int J Nanomedicine; 2013; 8():951-60. PubMed ID: 23486739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reinvention of chemotherapy: drug conjugates and nanoparticles.
    Nguyen-Ngoc T; Raymond E
    Curr Opin Oncol; 2015 May; 27(3):232-42. PubMed ID: 25783982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotechnology and nanomedicine: going small means aiming big.
    Teli MK; Mutalik S; Rajanikant GK
    Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.